ALS (motor neurone disease) trials in Sweden

In Sweden 8 Also abroad 226

8 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Where
Stockholm, Umeå
Age
18 years to 80 years
People
500 worldwide
Run by
Prilenia
See details and how to joinNCT07322003
Phase 1/2Taking people
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Where
Huddinge, Umeå
Age
18 years and over
People
54 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06351592 · EU 2023-510344-20-00
Phase 2Taking people
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Where
Malmo, Stockholm, Umea
Age
18 years and over
People
240 worldwide
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT07023835 · EU 2025-522580-15-00
Phase 1/2Taking people
A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis
Where
Huddinge, Umea
Age
18 years to 75 years
People
56 worldwide
Run by
Leal Therapeutics, Inc
See details and how to joinNCT07660614 · EU 2025-522039-33-00
Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Where
Stockholm, Umea
Age
18 years and over
People
420 worldwide
Run by
Ferrer Internacional S.A.
See details and how to join2025-524002-16-00 · EU 2025-524002-16-00
Phase 2Taking people
The Swedish BioFINDER 2 Study
Where
Malmö
Age
20 years to 100 years
People
2,950
Run by
Skane University Hospital
See details and how to joinNCT03174938 · EU 2024-511842-38-00
Phase 3Not yet taking people in Sweden
Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
Where
Umeå
Age
18 years to 80 years
People
412 worldwide
Run by
AB Science
See details and how to joinNCT07174492 · EU 2024-511244-12-01
Phase 3Taking people
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Where
Karlstad, Malmö, Umeå
Age
18 years to 81 years
People
495 worldwide
Run by
AB Science
See details and how to joinNCT03127267